Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.
Category: Drugs (Pharmaceuticals)
-
Stocks Edge Higher as Investors Assess Tariff Scenarios
The Trump administration’s chaotic tariff rollout continues to spur volatility in the markets.
-
UK Cuts Tariffs on Dozens of Products as Global Trade Tensions Rise
British officials also announced more financing for exporters as the country sought to protect firms hurt by tariffs.
-
RFK Jr. Accuses FDA of Drug Industry Influence That Barred Alternative Remedies
The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address the mass layoffs that have gutted oversight of tobacco and vapes, food safety and drug reviews.
-
India’s Drug Makers Shudder as Trump Again Threatens Tariffs
The United States is India’s biggest market for pharmaceutical exports, which are its most successful industrial exports.
-
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
-
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
-
Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.
-
Is the Poppers Party Over?
A potential crackdown on a readily available party drug seems to be afoot. But don’t panic just yet.
-
What to Know About Adderall, Ritalin and Other Prescription Stimulants
Health Secretary Robert F. Kennedy Jr. has called them poison, but doctors say prescription stimulants like Ritalin and Adderall help millions of people.